Skip to content

The effect of dexmedetomidine nasal spray on preoperative anxiety and postoperative quality of recovery in patients with lumbar degenerative diseases

The effect of dexmedetomidine nasal spray on preoperative anxiety and postoperative quality of recovery in patients with lumbar degenerative diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117763
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative anxiety

Interventions

Dexmedetomidine group:Nasal spray of dexmedetomidine
Control group:Nasal spray of normal saline

Sponsors

Zhengzhou Central Hospital Affiliated to Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age of 18-65 years old (2) ASA grade I-III (3) 18.5Kg/m2 <= BMI < 30 kg /m^2 (4) patients scheduled for elective posterior lumbar discectomy, spinal canal decompression, pedicle screw internal fixation, or lumbar fusion.

Exclusion criteria

Exclusion criteria: (1) Use of opioids, nonsteroidal anti-inflammatory drugs, gabapentin, benzodiazepines, or other prescription drugs with sedative or analgesic effects within one week before surgery; (2) Alcoholism (3) history of endocrine system diseases (4) sinus bradycardia or severe arrhythmia (5) complicated with severe hypertension and severe hepatic and renal insufficiency before operation (6) mental disorders (7) preoperative use of glucocorticoids 8) Expected procedure duration more than 3 hours

Design outcomes

Primary

MeasureTime frame
APAIS scores of patients at the time of admission to the operating room;

Secondary

MeasureTime frame
HADS - A before surgery and on the 1st, 2nd, and 3rd days after surgery.;Incidence of anxiety from the day of surgery to 3 days after surgery;The Richards-Campbell Sleep Questionnaire scores for the night before the surgery and the night after the surgery;The quality of recovery (QoR-15) scores at 1 day and 2 days after surgery were evaluated;Time to tracheal extubation;NRS scores at rest and during movement were recorded at 2h, 12h, 24h, 48h and 72h after surgery;Cumulative opioid consumption (morphine equivalent) at 24h, 48h and 72h after surgery;Preoperative and postoperative blood cortisol ;Preoperative and postoperative inflammatory factor levels (IL-1ß, IL-6, TNF-a, IL-10);Incidence of perioperative adverse events (including severe bradycardia, severe hypotension, postoperative nausea and vomiting, anaphylaxis, and delirium);PACU stay time;length of stay;

Countries

China

Contacts

Public ContactYan Wang

Zhengzhou Central Hospital Affiliated to Zhengzhou University

wangy0377@126.com+86 135 0371 4779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026